| Stromal gene expression predicts clinical outcome in breast cancer G Finak, N Bertos, F Pepin, S Sadekova, M Souleimanova, H Zhao, ... Nature medicine 14 (5), 518-527, 2008 | 1877 | 2008 |
| HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor AH Wang, NR Bertos, M Vezmar, N Pelletier, M Crosato, HH Heng, ... Molecular and cellular biology 19 (11), 7816-7827, 1999 | 392 | 1999 |
| Class II histone deacetylases: structure, function, and regulation NR Bertos, AH Wang, XJ Yang Biochemistry and cell biology 79 (3), 243-252, 2001 | 383 | 2001 |
| Breast cancer—one term, many entities? NR Bertos, M Park The Journal of clinical investigation 121 (10), 3789-3796, 2011 | 356 | 2011 |
| Regulation of histone deacetylase 4 by binding of 14-3-3 proteins AH Wang, MJ Kruhlak, J Wu, NR Bertos, M Vezmar, BI Posner, ... Molecular and cellular biology 20 (18), 6904-6912, 2000 | 344 | 2000 |
| miR-378∗ mediates metabolic shift in breast cancer cells via the PGC-1β/ERRγ transcriptional pathway LJ Eichner, MC Perry, CR Dufour, N Bertos, M Park, J St-Pierre, V Giguère Cell metabolism 12 (4), 352-361, 2010 | 333 | 2010 |
| Spatially distinct tumor immune microenvironments stratify triple-negative breast cancers T Gruosso, M Gigoux, VSK Manem, N Bertos, D Zuo, I Perlitch, SMI Saleh, ... The Journal of clinical investigation 129 (4), 1785-1800, 2019 | 319 | 2019 |
| Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and-independent mechanisms I Fernandes, Y Bastien, T Wai, K Nygard, R Lin, O Cormier, HS Lee, F Eng, ... Molecular cell 11 (1), 139-150, 2003 | 305 | 2003 |
| Regulation of global acetylation in mitosis through loss of histone acetyltransferases and deacetylases from chromatin MJ Kruhlak, MJ Hendzel, W Fischle, NR Bertos, S Hameed, XJ Yang, ... Journal of Biological Chemistry 276 (41), 38307-38319, 2001 | 245 | 2001 |
| RBP1 recruits the mSIN3-histone deacetylase complex to the pocket of retinoblastoma tumor suppressor family proteins found in limited discrete regions of the nucleus at growth … A Lai, BK Kennedy, DA Barbie, NR Bertos, XJ Yang, MC Theberge, ... Molecular and cellular biology, 2001 | 245 | 2001 |
| Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer AAN Rose, AA Grosset, Z Dong, C Russo, PA MacDonald, NR Bertos, ... Clinical cancer research 16 (7), 2147-2156, 2010 | 218 | 2010 |
| Identification of HDAC10, a novel class II human histone deacetylase containing a leucine-rich domain JJ Tong, J Liu, NR Bertos, XJ Yang Nucleic acids research 30 (5), 1114-1123, 2002 | 211 | 2002 |
| Primary tumors induce neutrophil extracellular traps with targetable metastasis-promoting effects RF Rayes, JG Mouhanna, I Nicolau, F Bourdeau, B Giannias, S Rousseau, ... JCI insight 4 (16), 2019 | 206 | 2019 |
| Role of the tetradecapeptide repeat domain of human histone deacetylase 6 in cytoplasmic retention NR Bertos, B Gilquin, GKT Chan, TJ Yen, S Khochbin, XJ Yang Journal of Biological Chemistry 279 (46), 48246-48254, 2004 | 190 | 2004 |
| Identification of a human histone acetyltransferase related to monocytic leukemia zinc finger protein N Champagne, NR Bertos, N Pelletier, AH Wang, M Vezmar, Y Yang, ... Journal of Biological Chemistry 274 (40), 28528-28536, 1999 | 187 | 1999 |
| Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes S Tabaries, Z Dong, MG Annis, A Omeroglu, F Pepin, V Ouellet, C Russo, ... Oncogene 30 (11), 1318-1328, 2011 | 174 | 2011 |
| CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary Y Xue, B Meehan, E Macdonald, S Venneti, XQD Wang, L Witkowski, ... Nature communications 10 (1), 558, 2019 | 111 | 2019 |
| Antibody colocalization microarray: a scalable technology for multiplex protein analysis in complex samples M Pla-Roca, RF Leulmi, S Tourekhanova, S Bergeron, V Laforte, ... Molecular & Cellular Proteomics 11 (4), 2012 | 101 | 2012 |
| The prognostic ease and difficulty of invasive breast carcinoma A Tofigh, M Suderman, ER Paquet, J Livingstone, N Bertos, SM Saleh, ... Cell reports 9 (1), 129-142, 2014 | 84 | 2014 |
| Targeting EZH2 reactivates a breast cancer subtype-specific anti-metastatic transcriptional program A Hirukawa, HW Smith, D Zuo, CR Dufour, P Savage, N Bertos, ... Nature communications 9 (1), 2547, 2018 | 79 | 2018 |
Morag ParkProfessor of Oncology and Biochemistry, McGill University, Director Goodman Cancer Research Centremcgill.ca üzerinde doğrulanmış e-posta adresine sahip
